Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 123 Pages
Report ld: 6469377
Request Sample
Customized Report
The global Radiofrequency Ablation Therapy Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Radiofrequency Ablation Therapy Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Radiofrequency ablation (RFA) is recognized as the most advanced fourth-generation physical therapy technology in the world. It has the advantages of minimally invasive, simple and precise curative effect. It has been recognized by both doctors and patients and has been widely developed at home and abroad.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Radiofrequency Ablation Therapy Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Radiofrequency Ablation Therapy Device. The Radiofrequency Ablation Therapy Device market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Radiofrequency Ablation Therapy Device market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Radiofrequency Ablation Therapy Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Radiofrequency Ablation Therapy Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Radiofrequency Ablation Therapy Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Radiofrequency Ablation Therapy Device Market Overview
1.1 Product Definition
1.2 Radiofrequency Ablation Therapy Device by Type
1.2.1 Global Radiofrequency Ablation Therapy Device Market Value by Type: 2025 vs 2032
1.2.2 RF Generators
1.2.3 Reusable Products
1.2.4 Disposable Products
1.3 Radiofrequency Ablation Therapy Device by Application
1.3.1 Global Radiofrequency Ablation Therapy Device Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Radiofrequency Ablation Therapy Device Market Size Estimates and Forecasts
1.4.1 Global Radiofrequency Ablation Therapy Device Revenue 2021–2032
1.4.2 Global Radiofrequency Ablation Therapy Device Sales 2021–2032
1.4.3 Global Radiofrequency Ablation Therapy Device Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Radiofrequency Ablation Therapy Device Market Competition by Manufacturers
2.1 Global Radiofrequency Ablation Therapy Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Radiofrequency Ablation Therapy Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Radiofrequency Ablation Therapy Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Radiofrequency Ablation Therapy Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Radiofrequency Ablation Therapy Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Radiofrequency Ablation Therapy Device, Product Types and Applications
2.7 Global Key Manufacturers of Radiofrequency Ablation Therapy Device, Date of Entry into the Industry
2.8 Global Radiofrequency Ablation Therapy Device Market Competitive Situation and Trends
2.8.1 Global Radiofrequency Ablation Therapy Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Radiofrequency Ablation Therapy Device Players Market Share by Revenue
2.8.3 Global Radiofrequency Ablation Therapy Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Radiofrequency Ablation Therapy Device Market Scenario by Region
3.1 Global Radiofrequency Ablation Therapy Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Radiofrequency Ablation Therapy Device Sales by Region: 2021–2032
3.2.1 Global Radiofrequency Ablation Therapy Device Sales by Region: 2021–2026
3.2.2 Global Radiofrequency Ablation Therapy Device Sales by Region: 2027–2032
3.3 Global Radiofrequency Ablation Therapy Device Revenue by Region: 2021–2032
3.3.1 Global Radiofrequency Ablation Therapy Device Revenue by Region: 2021–2026
3.3.2 Global Radiofrequency Ablation Therapy Device Revenue by Region: 2027–2032
3.4 North America Radiofrequency Ablation Therapy Device Market Facts & Figures by Country
3.4.1 North America Radiofrequency Ablation Therapy Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Radiofrequency Ablation Therapy Device Sales by Country (2021–2032)
3.4.3 North America Radiofrequency Ablation Therapy Device Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Radiofrequency Ablation Therapy Device Market Facts & Figures by Country
3.5.1 Europe Radiofrequency Ablation Therapy Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Radiofrequency Ablation Therapy Device Sales by Country (2021–2032)
3.5.3 Europe Radiofrequency Ablation Therapy Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Radiofrequency Ablation Therapy Device Market Facts & Figures by Region
3.6.1 Asia Pacific Radiofrequency Ablation Therapy Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Radiofrequency Ablation Therapy Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Radiofrequency Ablation Therapy Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Radiofrequency Ablation Therapy Device Market Facts & Figures by Country
3.7.1 Latin America Radiofrequency Ablation Therapy Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Radiofrequency Ablation Therapy Device Sales by Country (2021–2032)
3.7.3 Latin America Radiofrequency Ablation Therapy Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Radiofrequency Ablation Therapy Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Radiofrequency Ablation Therapy Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Radiofrequency Ablation Therapy Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Radiofrequency Ablation Therapy Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Radiofrequency Ablation Therapy Device Sales by Type (2021–2032)
4.1.1 Global Radiofrequency Ablation Therapy Device Sales by Type (2021–2026)
4.1.2 Global Radiofrequency Ablation Therapy Device Sales by Type (2027–2032)
4.1.3 Global Radiofrequency Ablation Therapy Device Sales Market Share by Type (2021–2032)
4.2 Global Radiofrequency Ablation Therapy Device Revenue by Type (2021–2032)
4.2.1 Global Radiofrequency Ablation Therapy Device Revenue by Type (2021–2026)
4.2.2 Global Radiofrequency Ablation Therapy Device Revenue by Type (2027–2032)
4.2.3 Global Radiofrequency Ablation Therapy Device Revenue Market Share by Type (2021–2032)
4.3 Global Radiofrequency Ablation Therapy Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Radiofrequency Ablation Therapy Device Sales by Application (2021–2032)
5.1.1 Global Radiofrequency Ablation Therapy Device Sales by Application (2021–2026)
5.1.2 Global Radiofrequency Ablation Therapy Device Sales by Application (2027–2032)
5.1.3 Global Radiofrequency Ablation Therapy Device Sales Market Share by Application (2021–2032)
5.2 Global Radiofrequency Ablation Therapy Device Revenue by Application (2021–2032)
5.2.1 Global Radiofrequency Ablation Therapy Device Revenue by Application (2021–2026)
5.2.2 Global Radiofrequency Ablation Therapy Device Revenue by Application (2027–2032)
5.2.3 Global Radiofrequency Ablation Therapy Device Revenue Market Share by Application (2021–2032)
5.3 Global Radiofrequency Ablation Therapy Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott Radiofrequency Ablation Therapy Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Avanos Medical
6.2.1 Avanos Medical Company Information
6.2.2 Avanos Medical Description and Business Overview
6.2.3 Avanos Medical Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Avanos Medical Radiofrequency Ablation Therapy Device Product Portfolio
6.2.5 Avanos Medical Recent Developments/Updates
6.3 Stryker
6.3.1 Stryker Company Information
6.3.2 Stryker Description and Business Overview
6.3.3 Stryker Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Stryker Radiofrequency Ablation Therapy Device Product Portfolio
6.3.5 Stryker Recent Developments/Updates
6.4 Boston Scientific
6.4.1 Boston Scientific Company Information
6.4.2 Boston Scientific Description and Business Overview
6.4.3 Boston Scientific Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Boston Scientific Radiofrequency Ablation Therapy Device Product Portfolio
6.4.5 Boston Scientific Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Company Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Medtronic Radiofrequency Ablation Therapy Device Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Diros Technology
6.6.1 Diros Technology Company Information
6.6.2 Diros Technology Description and Business Overview
6.6.3 Diros Technology Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Diros Technology Radiofrequency Ablation Therapy Device Product Portfolio
6.6.5 Diros Technology Recent Developments/Updates
6.7 Mianyang Leading Electronic Technology
6.7.1 Mianyang Leading Electronic Technology Company Information
6.7.2 Mianyang Leading Electronic Technology Description and Business Overview
6.7.3 Mianyang Leading Electronic Technology Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Mianyang Leading Electronic Technology Radiofrequency Ablation Therapy Device Product Portfolio
6.7.5 Mianyang Leading Electronic Technology Recent Developments/Updates
6.8 JJET
6.8.1 JJET Company Information
6.8.2 JJET Description and Business Overview
6.8.3 JJET Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 JJET Radiofrequency Ablation Therapy Device Product Portfolio
6.8.5 JJET Recent Developments/Updates
6.9 Wuhan BBT Medical
6.9.1 Wuhan BBT Medical Company Information
6.9.2 Wuhan BBT Medical Description and Business Overview
6.9.3 Wuhan BBT Medical Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Wuhan BBT Medical Radiofrequency Ablation Therapy Device Product Portfolio
6.9.5 Wuhan BBT Medical Recent Developments/Updates
6.10 Medsphere International
6.10.1 Medsphere International Company Information
6.10.2 Medsphere International Description and Business Overview
6.10.3 Medsphere International Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Medsphere International Radiofrequency Ablation Therapy Device Product Portfolio
6.10.5 Medsphere International Recent Developments/Updates
6.11 Angel Medical
6.11.1 Angel Medical Company Information
6.11.2 Angel Medical Description and Business Overview
6.11.3 Angel Medical Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Angel Medical Radiofrequency Ablation Therapy Device Product Portfolio
6.11.5 Angel Medical Recent Developments/Updates
6.12 Surgnova Healthcare Technologies
6.12.1 Surgnova Healthcare Technologies Company Information
6.12.2 Surgnova Healthcare Technologies Description and Business Overview
6.12.3 Surgnova Healthcare Technologies Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Surgnova Healthcare Technologies Radiofrequency Ablation Therapy Device Product Portfolio
6.12.5 Surgnova Healthcare Technologies Recent Developments/Updates
6.13 Tianjin Simon Medical Technology
6.13.1 Tianjin Simon Medical Technology Company Information
6.13.2 Tianjin Simon Medical Technology Description and Business Overview
6.13.3 Tianjin Simon Medical Technology Radiofrequency Ablation Therapy Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Tianjin Simon Medical Technology Radiofrequency Ablation Therapy Device Product Portfolio
6.13.5 Tianjin Simon Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Radiofrequency Ablation Therapy Device Industry Chain Analysis
7.2 Radiofrequency Ablation Therapy Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Radiofrequency Ablation Therapy Device Production Mode & Process Analysis
7.4 Radiofrequency Ablation Therapy Device Sales and Marketing
7.4.1 Radiofrequency Ablation Therapy Device Sales Channels
7.4.2 Radiofrequency Ablation Therapy Device Distributors
7.5 Radiofrequency Ablation Therapy Device Customer Analysis
8 Radiofrequency Ablation Therapy Device Market Dynamics
8.1 Radiofrequency Ablation Therapy Device Industry Trends
8.2 Radiofrequency Ablation Therapy Device Market Drivers
8.3 Radiofrequency Ablation Therapy Device Market Challenges
8.4 Radiofrequency Ablation Therapy Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Radiofrequency Ablation Therapy Device was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 140
USD 3950.00
(Single User License)
The global Radiofrequency Ablation Therapy Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 97
USD 4250.00
(Single User License)
The global Radiofrequency Ablation Therapy Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 155
USD 4900.00
(Single User License)
The global market for Radiofrequency Ablation Therapy Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 112
USD 3950.00
(Single User License)
The global market for Radiofrequency Ablation Therapy Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 90
USD 2900.00
(Single User License)
Radiofrequency ablation (RFA) is recognized as the most advanced fourth-generation physical therapy technology in the world. It has the advantages of minimally invasive, simple and precise curative effect. It has been recognized by both doctors and patients and has been widely developed at home and abroad.
Published Date: 2024-04-28
Pages: 111
USD 4900.00
(Single User License)
Radiofrequency ablation (RFA) is recognized as the most advanced fourth-generation physical therapy technology in the world. It has the advantages of minimally invasive, simple and precise curative effect. It has been recognized by both doctors and patients and has been widely developed at home and abroad.
Published Date: 2024-01-18
Pages: 96
USD 2900.00
(Single User License)
The global market for Radiofrequency Ablation Therapy Device was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 140
The global Radiofrequency Ablation Therapy Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 97
The global Radiofrequency Ablation Therapy Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 155
The global market for Radiofrequency Ablation Therapy Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 112
The global market for Radiofrequency Ablation Therapy Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 90
Radiofrequency ablation (RFA) is recognized as the most advanced fourth-generation physical therapy technology in the world. It has the advantages of minimally invasive, simple and precise curative effect. It has been recognized by both doctors and patients and has been widely developed at home and abroad.
Published: 2024-04-28
Pages: 111
Radiofrequency ablation (RFA) is recognized as the most advanced fourth-generation physical therapy technology in the world. It has the advantages of minimally invasive, simple and precise curative effect. It has been recognized by both doctors and patients and has been widely developed at home and abroad.
Published: 2024-01-18
Pages: 96
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now